JACK W CALLICUTT
CIK 1266773 · Chief Financial Officer · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.3K
Companies
2
Total Filings
32
Lifetime Open-Market Net
-$3.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALT | Chief Financial Officer | 7,614 | $2.67 | $20.3K | -$3.98M | 24 | 2026-01-21 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Chief Financial Officer | 1,260 | — | — | $6.2K | 7 | 2016-12-06 |
Recent Filings · Page 2 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-30 | GALT | Grant (A) | — | $0 | EDGAR |
| 2022-11-17 | GALT | Buy (P) | +4,000 | $5.3K | EDGAR |
| 2022-01-25 | GALT | Grant (A) | — | $0 | EDGAR |
| 2021-03-29 | GALT | Grant (A) | — | $0 | EDGAR |
| 2020-01-13 | GALT | Grant (A) | — | $0 | EDGAR |
| 2019-06-03 | GALT | Buy (P) | +2,354 | $10.1K | EDGAR |
| 2019-01-18 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-06-21 | GALT | Mixed | — | -$974.3K | EDGAR |
| 2018-06-14 | GALT | Mixed | — | -$52.4K | EDGAR |
| 2018-06-12 | GALT | Mixed | — | -$588.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.